Skip to main content

Table 3 TNM Staging. Group I, patients who were diagnosed histologically; Group II, patients who were diagnosed radiologically

From: Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data

TNM stage* Group I (n = 2920) Group II (n = 5562)
Stage I (n, %) 329(11.3) 1,065(19.1)
Stage II (n, %) 1,512(51.8) 1,875(33.7)
Stage III (n, %) 438(15.0) 1,507(27.1)
Stage IV-A (n, %) 60(2.1) 631(11.3)
Stage IV-B (n, %) 50(1.7) 456(8.2)
Undefined (n, %) 531(18.2) 28(0.5)